Market Tracker

02/21 5:16pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

65.68
Delayed Data
As of Feb 21
 +0.18 / +0.27%
Today’s Change
28.32
Today|||52-Week Range
75.36
+24.46%
Year-to-Date
7 Stocks That Are Beating the Market
Feb 21 / GuruFocus News - Paid Partner Content
Seattle Genetics Earnings: Waiting on ECHELON
Feb 13 / MotleyFool.com - Paid Partner Content
Gurus' Worst Recent Investments
Feb 15 / GuruFocus News - Paid Partner Content
Seattle Genetics (SGEN) Loss Wider than Expected in Q4, Revenues Miss
Feb 10 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Present...
Feb 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close65.50
Today’s open65.50
Day’s range64.88 - 65.97
Volume625,405
Average volume (3 months)1,235,851
Market cap$9.3B
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)-72.60%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+24.15%
P/E ratioNM
Price/Sales17.76
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-0.09-0.05%
ALKSAlkermes Plc-0.38-0.70%
JAZZJazz Pharmaceuticals...-1.26-0.92%
RDYDr.Reddy's Laborator...+0.24+0.55%
Data as of 4:02pm ET, 02/21/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$418.1M
Annual profit (last year)-$140.1M
Net profit margin-33.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts